Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Total revenue	$ 5,115	$ 737	$ 13,201	$ 2,303
Operating expenses:
Product cost of goods sold	1,440	0	4,259	0
Research and development	4,288	4,251	12,265	15,926
Selling, general and administrative	8,562	2,969	27,151	8,086
Amortization of intangible assets	443	0	1,112	0
Change in fair value of contingent consideration	186	0	(268)	0
Impairment loss on long-lived assets	0	0	0	114
Total operating expenses	14,919	7,220	44,519	24,126
Operating loss	(9,804)	(6,483)	(31,318)	(21,823)
Other income (expense), net:
Interest income	38	4	56	10
Interest expense	(635)	0	(1,375)	0
Gain on debt extinguishment	4,340	0	4,340	956
Other income (expense)	31	(5)	9	(602)
Total other income (expense), net	3,774	(1)	3,030	364
Net loss	(6,030)	(6,484)	(28,288)	(21,459)
Comprehensive loss	$ (6,030)	$ (6,484)	$ (28,288)	$ (21,459)
Net loss per share, basic (in USD per share)	$ (0.25)	$ (0.34)	$ (1.33)	$ (1.30)
Net loss per share, diluted (in USD per share)	$ (0.25)	$ (0.34)	$ (1.33)	$ (1.30)
Weighted-average number of shares outstanding, basic (in shares)	24,462,228	18,813,653	21,189,799	16,476,235
Weighted-average common shares outstanding, diluted (in shares)	24,462,228	18,813,653	21,189,799	16,476,235
Net product revenues
Revenue from contract with customer	$ 4,605	$ 0	$ 11,131	$ 0
License and collaboration revenues
Revenue from contract with customer	492	680	2,010	2,174
Government research contracts and grants revenue
Government research contracts and grants revenue	$ 18	$ 57	$ 60	$ 129